Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Changle, Shi"'
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundDermatofibrosarcoma protuberans (DFSP) is an uncommon cutaneous tumor in children. Most published articles are sporadic or small series and lack systematically molecular analyses. The aim of our study is to better understand the clinicopath
Externí odkaz:
https://doaj.org/article/e9a91d942d684829b1cb8885047408b7
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
ALK-positive histiocytosis (APH) is a rare and recently described, solitary or generalized, histiocytic proliferative disorder with a characteristic gene translocation involving the fusion of the ALK gene at chromosome 2p23. To date, only 25 cases of
Externí odkaz:
https://doaj.org/article/fe925599f87447b695e5091da4079873
Autor:
Lijuan Yin, Changle Shi, Xin He, Yan Qiu, Huijiao Chen, Min Chen, Zhang Zhang, Yihua Chen, Yanyan Zhou, Hongying Zhang
Publikováno v:
Pathology. 55:362-374
Publikováno v:
In Oral Oncology May 2015 51(5):483-492
Publikováno v:
2022 8th International Conference on Hydraulic and Civil Engineering: Deep Space Intelligent Development and Utilization Forum (ICHCE).
Autor:
Xuelei Ma, Xiaoshan Wang, Jingwen Huang, Yingtai Chen, Jing Zhang, Binglan Zhang, Changle Shi, Lei Liu
Publikováno v:
PLoS ONE, Vol 11, Iss 8, p e0160148 (2016)
Neoadjuvant therapy is administered to breast cancer patients as an induction process before surgery or radiotherapy to reduce tumor size. Human epidermal growth factor receptor-2 (HER-2) negative breast cancer lacks effective standard target therapy
Externí odkaz:
https://doaj.org/article/a77ff75a27074143a270ab66d85ac761
Autor:
Jiawei Qian, Changle Shi
Publikováno v:
2021 7th International Conference on Hydraulic and Civil Engineering & Smart Water Conservancy and Intelligent Disaster Reduction Forum (ICHCE & SWIDR).
Autor:
Jing Zhang, Binglan Zhang, Lei Liu, Jingwen Huang, Xiaoshan Wang, Xuelei Ma, Changle Shi, Yingtai Chen
Publikováno v:
PLoS ONE
PLoS ONE, Vol 11, Iss 8, p e0160148 (2016)
PLoS ONE, Vol 11, Iss 8, p e0160148 (2016)
Background Neoadjuvant therapy is administered to breast cancer patients as an induction process before surgery or radiotherapy to reduce tumor size. Human epidermal growth factor receptor-2 (HER-2) negative breast cancer lacks effective standard tar
Autor:
Jingwen Huang, Jing Zhang, Changle Shi, Lei Liu, Yuquan Wei, Huang, Jingwen, Zhang, Jing, Shi, Changle, Liu, Lei, Wei, Yuquan
Publikováno v:
BMC Cancer; 8/26/2016, Vol. 16, p1-16, 16p, 1 Diagram, 11 Charts, 2 Graphs